Patou, Gary

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 20% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Patou, Gary's trades of Xenon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-09 2026-06-05
S Sale
84,222 -45.5%
448.99
US$1,811,847 		84,222 -45.5% 448.99 US$1,811,847
2024-12-18 2024-11-22
S Sale
73,811 +20.2%
147.13
US$856,537 		73,811 +20.2% 147.13 US$856,537
2024-12-18 2024-11-22
S Sale
29,959 -22.5%
463.60
US$4,966,440 		29,959 -22.5% 463.60 US$4,966,440
2024-12-18 2024-11-22
B Purchase
3,086 +13.1%
13.48
US$41,599 		3,086 +13.1% 13.48 US$41,599
2024-12-18 2024-11-22
S Sale
2,851 -10.8%
41.11
US$117,205 		2,851 -10.8% 41.11 US$117,205
2023-12-18 2023-12-14
S Sale
7,598 -60.8%
41.05
US$311,898 		7,598 -60.8% 41.05 US$311,898
2023-12-18 2023-12-13
S Sale
3,977 -14.4%
39.84
US$158,444 		3,977 -14.4% 39.84 US$158,444
2023-12-18 2023-12-13
S Sale
2,303 -8.9%
39.10
US$90,047 		2,303 -8.9% 39.10 US$90,047
2023-12-18 2023-12-13
S Sale
5,100 -17.8%
38.94
US$198,594 		5,100 -17.8% 38.94 US$198,594
2022-11-28 2022-11-25
S Sale
1,937 -7.6%
34.79
US$67,390 		1,937 -7.6% 34.79 US$67,390
2022-11-28 2022-11-23
S Sale
2,057 -8.0%
34.33
US$70,610 		2,057 -8.0% 34.33 US$70,610